Workflow
内部控制缺陷
icon
Search documents
深夜突发公告:“80后”董事长乔文健被留置!他年薪超166万元
Mei Ri Jing Ji Xin Wen· 2025-11-25 07:12
11月24日深夜,ST长园(SH600525,股价3.76元,市值49.59亿元,以下称长园集团)公告称,公司当天收到惠州市惠阳区监察委员会签发的关于公司董 事长兼法定代表人乔文健的《留置通知书》,乔文健因涉嫌职务违法被实施留置。 每经记者|陈鹏丽 每经编辑|何小桃 黄博文 乔文健,视频截图 "80后"董事长"突然"被实施留置 长园集团称,上述事项不会对公司正常生产经营产生重大不利影响。截至11月24日,公司未收到有权机关对公司的任何调查或者配合调查文件,暂未知悉 留置调查的进展及结论。 公开资料显示,乔文健系1983年出生。他于2021年加入长园集团,历任长园集团董事长特别助理、副总裁、总裁。2025年9月26日,乔文健被选举为公司 董事长。2024年度,他从长园集团获取的税前报酬总额超166万元。 需要注意的是,2025年4月,长园集团前任董事长吴启权所控制的珠海市运泰利控股发展有限公司(以下简称"运泰利控股")被指通过第三方占用上市公 司资金。2025年9月12日,吴启权辞去在公司的所有职务,包括董事长职务。乔文健接棒成为公司董事长。 11月25日上午,《每日经济新闻》记者拨通长园集团董秘办公室的电话, ...
内控问题不断,捷强装备被责令改正
Shen Zhen Shang Bao· 2025-11-19 14:11
Core Viewpoint - Tianjin Jieqiang Power Equipment Co., Ltd. has received administrative regulatory measures from the Tianjin Securities Regulatory Bureau due to internal control deficiencies in financial and contract management, leading to warnings issued to key personnel [1][3][4] Group 1: Regulatory Actions - The company was ordered to rectify issues related to fund management and contract management, and four key personnel received warning letters [1][4] - The regulatory decision was based on findings that the company used personal bank accounts for transactions and signed false business contracts [3][4] Group 2: Company Background and Challenges - The company is involved in the research, production, and sales of core components for nuclear biological defense equipment, with a focus on hydraulic power systems for military vehicles [5] - The former chairman and general manager, Pan Feng, is embroiled in a bribery case, which has further complicated the company's situation [5][6] Group 3: Financial Performance - For the first three quarters of 2025, the company reported a revenue of 169 million yuan, an increase of 8.07% year-on-year, but a net loss attributable to shareholders of 23.19 million yuan, a decline of 146.20% [6] - The company has only one institutional investor holding 5.22% of its total shares, indicating limited investor confidence [6]
捷强装备:天津证监局对公司采取责令改正措施
Zhi Tong Cai Jing· 2025-11-19 08:35
决定书指出:公司存在资金管理、合同管理内部控制缺陷,未建立健全财务、会计管理制度。一是2022 年9月至2025年3月公司通过职工个人银行卡代收付相关款项。二是公司于2022年、2023年签订不真实业 务合同并发生资金收支往来(未确认收入、成本)。三是公司个别委外研发合同未按合同约定执行,提前 支付款项。 捷强装备(300875)(300875.SZ)公告,公司近日收到中国证券监督管理委员会天津监管局出具的《关 于对天津捷强动力装备股份有限公司采取责令改正并对潘峰、徐本友、潘淇靖、纪滋强采取出具警示函 措施的决定》。 ...
捷强装备(300875.SZ):天津证监局对公司采取责令改正措施
智通财经网· 2025-11-19 08:31
智通财经APP讯,捷强装备(300875.SZ)公告,公司近日收到中国证券监督管理委员会天津监管局出具的 《关于对天津捷强动力装备股份有限公司采取责令改正并对潘峰、徐本友、潘淇靖、纪滋强采取出具警 示函措施的决定》。 决定书指出:公司存在资金管理、合同管理内部控制缺陷,未建立健全财务、会计管理制度。一是2022 年9月至2025年3月公司通过职工个人银行卡代收付相关款项。二是公司于2022年、2023年签订不真实业 务合同并发生资金收支往来(未确认收入、成本)。三是公司个别委外研发合同未按合同约定执行,提前 支付款项。 ...
捷强装备:收到天津证监局对公司采取责令改正并对相关人员采取出具警示函措施
Xin Lang Cai Jing· 2025-11-19 08:24
捷强装备公告,近日收到天津证监局出具的《关于对天津捷强动力装备股份有限公司采取责令改正并对 潘峰、徐本友、潘淇靖、纪滋强采取出具警示函措施的决定》。经查,公司存在资金管理、合同管理内 部控制缺陷,未建立健全财务、会计管理制度。一是2022年9月至2025年3月公司通过职工个人银行卡代 收付相关款项。二是公司于2022年、2023年签订不真实业务合同并发生资金收支往来(未确认收入、成 本)。三是公司个别委外研发合同未按合同约定执行,提前支付款项。 ...
骑士乳业期货投机巨亏未披露,内控缺陷暗藏多重经营风险
Xin Lang Zheng Quan· 2025-11-19 08:11
登录新浪财经APP 搜索【信披】查看更多考评等级 骑士乳业因期货投资巨亏却"秘而不宣",被推至舆论的风口浪尖。这家北交所"乳业第一股"因涉嫌信息 披露违法违规,公司及相关当事人被证监会立案调查,并收到监管部门的行政处罚事先告知书。 期货投机的雪球越滚越大,而市场却在很长时间内对此一无所知。根据调查,骑士乳业存在多次应披露 而未及时披露期货交易重大亏损的情形,亏损金额在相当长的时间内持续扩大。 01 监管与法律风险高悬 骑士乳业此次事件首先暴露的是其面临的严峻监管与法律风险。 公司因未及时披露期货交易重大亏损事项,涉嫌信息披露违法违规,已被证监会正式立案。这不仅导致 公司面临罚款,相关董监高人员也一同被罚,凸显了监管层对上市公司信息披露合规性的"零容忍"态 度。 更严重的是,此类信息披露违规行为可能引发投资者的集体诉讼。法律专业人士指出,信息披露义务人 未按照规定披露信息,致使投资者在证券交易中遭受损失的,受损投资者有权依法要求赔偿。 这并非骑士乳业首次触碰信披"红线"。今年早些时候,公司就曾因业绩预告披露不准确且未能及时修正 等问题,被北交所给予通报批评的纪律处分。连续的信披违规记录,进一步加剧了公司的监管风 ...
从预盈3500万到巨亏3.48亿:ST华西“变脸”业绩预告引发的连锁惨案
Core Viewpoint - ST Huaxi (002630.SZ) has faced significant scrutiny following a public reprimand from the Shenzhen Stock Exchange due to a major discrepancy between its 2024 performance forecast and the audited net profit, indicating serious internal control deficiencies [1][3]. Group 1: Performance Discrepancy - ST Huaxi initially projected a net profit of 35 million yuan for 2024, but later revised this to a loss of 3.81 billion yuan, ultimately reporting a net loss of 3.48 billion yuan [2][3]. - The drastic change in performance led to market panic, with the stock price hitting the daily limit down prior to the annual report release, resulting in significant investor losses [2][3]. Group 2: Regulatory Actions - The Shenzhen Stock Exchange issued a public reprimand to ST Huaxi and its executives for failing to fulfill their duties, highlighting the violation of relevant laws due to the significant difference between the performance forecast and actual results [3]. - This is not the first regulatory action against ST Huaxi; the company had previously received a warning due to an internal control audit that was deemed unable to express an opinion [3]. Group 3: Management Changes - Following the regulatory scrutiny, there were significant changes in the management team, including the resignation of Chairman and CEO Li Renchao, who faced legal issues [4]. - The company’s Secretary of the Board, Meng Haitao, also resigned due to the public reprimand but will continue in other executive roles [4]. Group 4: Financial Performance - Despite revenue growth of 117.30% in 2023 and 38.91% in 2024, ST Huaxi has not managed to escape its loss-making situation, with a reported revenue decline of 29.50% in the first three quarters of 2025 [5][6]. - The cumulative losses over five years from 2020 to 2024 amount to approximately 24.46 billion yuan, with annual losses ranging from 1.93 billion to 7.57 billion yuan [4][5]. Group 5: Remedial Actions - In response to the internal control issues and regulatory penalties, ST Huaxi has established a rectification leadership team and is actively working on a comprehensive overhaul of its internal control systems [6][7]. - Some corrective measures have been completed, including the standardization of payment accounts and related party transactions, but the company acknowledges that other issues are still in the process of being addressed [6][7]. Group 6: Future Outlook - The company faces a critical year in 2025, as failure to rectify internal control issues could lead to delisting risks, emphasizing the urgency of their remedial actions [7]. - ST Huaxi's main business segments include equipment manufacturing, engineering contracting, and investment operations, with a revenue composition heavily reliant on total contracting projects [8].
上交所对科达制造及有关责任人予以通报批评
Mei Ri Jing Ji Xin Wen· 2025-10-31 10:42
Group 1: Core Issues - Keda Manufacturing has been criticized for violations in information disclosure and operational norms, including off-the-books transactions and improper accounting practices [2][4] - The company has engaged in off-the-books payments through employees' personal bank accounts, affecting reported profits in 2022, 2023, 2024, and the first half of 2025, with impacts of 0.12%, 0.81%, 1.09%, and 0.29% respectively [2] - There were unauthorized salary payments to executives that were not reviewed or disclosed as required, with these payments being returned to the company by the end of September 2025 [3] Group 2: Responsibility and Disciplinary Actions - The responsible parties, including the former chairman and general managers, failed to fulfill their duties, leading to inaccurate disclosures and violations of multiple stock exchange regulations [5][7] - The Shanghai Stock Exchange has decided to issue a public reprimand to Keda Manufacturing and the involved executives due to the clear violations and the deficiencies in the company's internal control systems [7][8] - The company is required to submit a rectification report within one month, signed by all senior management, to address the compliance issues identified [8] Group 3: Financial Overview - As of the latest report, Keda Manufacturing's market capitalization stands at 25.1 billion yuan [9] - The company's revenue composition for 2024 includes 53.32% from the machinery equipment sector, 37.42% from the overseas ceramics sector, 6.99% from lithium battery materials, and 2.19% from other equipment [8]
Organon(OGN.US)因内部控制问题重挫,再遭Piper Sandler大砍目标价至5美元
智通财经网· 2025-10-28 07:01
Core Viewpoint - Piper Sandler downgraded Organon (OGN.US) from "Overweight" to "Underweight" and reduced the target price from $18 to $5 due to significant internal control deficiencies revealed during an audit committee investigation, affecting financial statements for 2022, 2024, and 2025 [1] Company Summary - The downgrade indicates a long recovery path for Organon, primarily due to the need to restore internal controls and investor confidence [1] - Following the downgrade, Organon's stock price fell approximately 23% [1] - Analysts caution that the current uncertainty and the company's journey to profitability will be lengthy and challenging, potentially increasing risk and volatility [1]
深圳一上市公司停牌!时任董事长及3高管被警示,已连亏4年
Nan Fang Du Shi Bao· 2025-10-24 03:50
Core Viewpoint - Shenzhen Securities Regulatory Bureau has imposed corrective measures on Shenzhen Baoying Construction Holding Group Co., Ltd. due to internal control deficiencies and inaccurate information disclosure [1][2] Group 1: Regulatory Actions - The Shenzhen Securities Regulatory Bureau issued a decision to order the company to make corrections and issued warning letters to key executives including Hu Jia, Xiao Jiahe, Xue Wen, and Liu Cheng [1][2] - The company is required to submit a written rectification report within 30 days of receiving the decision [2] Group 2: Internal Control Issues - The company was found to have deficiencies in internal controls related to project management, procurement management, and fund management [1] - Inaccurate disclosure regarding cash donations from related parties in December 2024 was highlighted as a significant issue [1] Group 3: Executive Changes - The company has experienced frequent changes in senior management since the beginning of the year, with multiple executives resigning between March and August 2025 [7][9][10] - Notable resignations include the CFO Xue Wen and Vice General Manager Gao Chuanyu, both citing personal reasons [9] Group 4: Financial Performance - The company has reported continuous losses for four consecutive years, totaling over 5.5 billion [14][15] - For the fiscal year 2024, the company achieved a revenue of 2.112 billion, a year-on-year decrease of 48.63%, and a net loss of 742 million, a reduction in loss of 23.52% compared to the previous year [15] Group 5: Corporate Governance - The company’s board of directors has seen significant turnover, with the appointment of Li Peng as the new chairman following the resignation of former chairman Lü Haitao [10] - The company has been criticized for increasing executive compensation despite ongoing financial losses, with total compensation for directors and executives rising from 7.57 million in 2022 to 11.54 million in 2024 [15]